Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Susan M. Cole
Observed names:
S Cole,
S. Cole,
S. M. Cole,
S.M. Cole,
Susan Cole
Institution:
Medicines and Healthcare products Regulatory Agency
Observed institutions:
European Medicines Agency,
Pfizer (United Kingdom),
Medicines and Healthcare products Regulatory Agency,
University College London
ORCID:
0000-0002-4582-6231
Observed ORCID:
0000-0002-4582-6231
OpenAlex ID:
A5068622970
Prediction of Human Pharmacokinetics From Preclinical Information: Comparative Accuracy of Quantitative Prediction Approaches
2009
·
Natilie A. Hosea
, Wendy T. Collard
, et al.
·
The Journal of Clinical Pharmacology
·
314
Predicting Penetration Across the Blood-Brain Barrier from Simple Descriptors and Fragmentation Schemes
2006
·
Yuan H. Zhao
, Michael H. Abraham
, et al.
·
Journal of Chemical Information and Modeling
·
149
Physiologically based pharmacokinetic modeling in regulatory decision‐making at the European Medicines Agency
2016
·
E Luzon
, K Blake
, et al.
·
Clinical Pharmacology & Therapeutics
·
145
Simulation of Human Intravenous and Oral Pharmacokinetics of 21 Diverse Compounds Using Physiologically Based Pharmacokinetic Modelling
2011
·
Hannah M. Jones
, Iain B. Gardner
, et al.
·
Clinical Pharmacokinetics
·
120
The Discovery of a Potent, Selective, and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of Pain
2016
·
Sarah E. Skerratt
, Mark Andrews
, et al.
·
Journal of Medicinal Chemistry
·
89
PDF
The Importance of the Human Mass Balance Study in Regulatory Submissions
2019
·
Paola Coppola
, Anita Andersson
, et al.
·
CPT Pharmacometrics & Systems Pharmacology
·
82
PDF
Physiologically Based Models in Regulatory Submissions: Output From the ABPI/MHRA Forum on Physiologically Based Modeling and Simulation
2015
·
T Shepard
, G Scott
, et al.
·
CPT Pharmacometrics & Systems Pharmacology
·
82
PDF
Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014)
2017
·
FT Musuamba
, E Manolis
, et al.
·
CPT Pharmacometrics & Systems Pharmacology
·
73
PDF
Lipophilicity and Other Parameters Affecting Brain Penetration
2002
·
F. Atkinson
, S. Cole
, et al.
·
Central Nervous System Agents in Medicinal Chemistry
·
72
Covariate modeling in pharmacometrics: General points for consideration
2024
·
Kinjal Sanghavi
, Jakob Ribbing
, et al.
·
CPT Pharmacometrics & Systems Pharmacology
·
66
PDF
Discovery of a Selective Small-Molecule Melanocortin-4 Receptor Agonist with Efficacy in a Pilot Study of Sexual Dysfunction in Humans
2010
·
Mark I. Lansdell
, David Hepworth
, et al.
·
Journal of Medicinal Chemistry
·
48
Physiologically Based Pharmacokinetics Model in Pregnancy: A Regulatory Perspective on Model Evaluation
2021
·
Paola Coppola
, Essam Kerwash
, et al.
·
Frontiers in Pediatrics
·
47
PDF
PD168077, a D 4 receptor agonist, reverses object recognition deficits in rats: potential role for D 4 receptor mechanisms in improving cognitive dysfunction in schizophrenia
2010
·
Pooja Sood
, Nagi F Idris
, et al.
·
Journal of Psychopharmacology
·
38
A Novel Series of Potent and Selective PDE5 Inhibitors with Potential for High and Dose-Independent Oral Bioavailability
2006
·
Charlotte M. N. Allerton
, Christopher G. Barber
, et al.
·
Journal of Medicinal Chemistry
·
35
The discovery of UK-369003, a novel PDE5 inhibitor with the potential for oral bioavailability and dose-proportional pharmacokinetics
2011
·
David J. Rawson
, Stephen Ballard
, et al.
·
Bioorganic & Medicinal Chemistry
·
32
Full efficacy with no CNS side-effects: unachievable panacea or reality? DMPK considerations in design of drugs with limited brain penetration
2011
·
Susan Cole
, Sharan Bagal
, et al.
·
Xenobiotica
·
32
A summary of the current drug interaction guidance from the European Medicines Agency and considerations of future updates
2020
·
Susan Cole
, Essam Kerwash
, et al.
·
Drug Metabolism and Pharmacokinetics
·
31
Pharmacokinetic data in pregnancy: A review of available literature data and important considerations in collecting clinical data
2022
·
Paola Coppola
, Essam Kerwash
, et al.
·
Frontiers in Medicine
·
28
PDF
Commentary on the MID3 Good Practices Paper
2017
·
Efthymios Manolis
, Jacob Brogren
, et al.
·
CPT Pharmacometrics & Systems Pharmacology
·
28
PDF
Evaluation of metaquant microdialysis for measurement of absolute concentrations of amphetamine and dopamine in brain: A viable method for assessing pharmacokinetic profile of drugs in the brain
2009
·
Pooja Sood
, Susan Cole
, et al.
·
Journal of Neuroscience Methods
·
27
Total and Free Blood and Plasma Concentration Changes in Pregnancy for Medicines Highly Bound to Plasma Proteins: Application of Physiologically Based Pharmacokinetic Modelling to Understand the Impact on Efficacy
2023
·
Paola Coppola
, Andrew Butler
, et al.
·
Pharmaceutics
·
19
PDF
The Use of Pregnancy Physiologically Based Pharmacokinetic Modeling for Renally Cleared Drugs
2022
·
Paola Coppola
, Essam Kerwash
, et al.
·
The Journal of Clinical Pharmacology
·
19
Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar Series
2022
·
Mark McAllister
, Talia Flanagan
, et al.
·
Pharmaceutics
·
19
PDF
Pharmacokinetic Characterization to Enable Medicine Use in Pregnancy, the Potential Role of Physiologically‐Based Pharmacokinetic Modeling: A Regulatory Perspective
2020
·
Susan Cole
, Paola Coppola
, et al.
·
CPT Pharmacometrics & Systems Pharmacology
·
14
PDF
Reductive sulfenylation. A general method for the .alpha.-sulfenylation of cyclic ketones
1977
·
Paul G. Gassman
, David P. Gilbert
, et al.
·
The Journal of Organic Chemistry
·
14
Show more works
View as search
Works count:
43
Citation count:
1,701
H-index:
20
I10-index:
28
Year
Topic
Type